The iShares Emerging Markets Equity Factor ETF (EMGF) seeks to track an emerging markets equity factor index that applies quality, momentum, and low volatility screens to stocks from developing countries including China, India, Taiwan, and Brazil. This multi-factor approach targets companies with strong fundamentals and stable price performance across emerging market economies.
How It Works
EMGF uses a rules-based methodology that screens emerging market stocks across multiple factors including quality metrics (return on equity, debt-to-equity), momentum indicators (price trends), and low volatility characteristics. The fund employs a market-cap weighted approach within factor constraints, rebalancing quarterly to maintain factor exposures. Holdings span approximately 200-300 companies across major emerging markets, with systematic exclusion of the most volatile and fundamentally weak stocks that typically dominate broad emerging market indices.
Key Features
- Multi-factor screening reduces exposure to volatile, low-quality emerging market companies that often drag down broad EM returns
- Targets quality companies with strong balance sheets and earnings stability, unusual focus for emerging market investing
- Provides 3.09% dividend yield while maintaining factor discipline across diverse developing economies including Asia and Latin America
Risks
- This ETF can lose significant value during emerging market selloffs, potentially declining 40-60% when global investors flee developing countries during crises
- Currency fluctuations can severely impact returns when emerging market currencies weaken against the U.S. dollar during global uncertainty
- Factor strategies can underperform for extended periods when markets favor growth over quality, momentum, or low volatility characteristics
Who Should Own This
Best suited as a satellite holding (5-15% of equity allocation) for experienced investors with high risk tolerance and 7+ year time horizons seeking emerging market exposure with reduced volatility. Appropriate for investors who want developing market growth potential but prefer systematic risk management over broad market beta exposure.